Park Edge Advisors’s Pfizer PFE Stock Holding History

Park Edge Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492K	Sell	20,416 -1,982	-9%	-$51.8K	0.1%	104
2026 Q1	$629K	Sell	22,398 -1,532	-6%	-$40.8K	0.15%	85
2025 Q4	$596K	Hold	23,930	–	–	0.13%	94
2025 Q3	$610K	Hold	23,930	–	–	0.14%	88
2025 Q2	$580K	Sell	23,930 -1,204	-5%	-$28.1K	0.15%	89
2025 Q1	$637K	Sell	25,134 -299	-1%	-$7.82K	0.18%	80
2024 Q4	$675K	Sell	25,433 -805	-3%	-$21.8K	0.2%	79
2024 Q3	$759K	Buy	26,238 +1	+0%	+$29	0.22%	80
2024 Q2	$734K	Hold	26,237	–	–	0.22%	71
2024 Q1	$728K	Sell	26,237 -1,980	-7%	-$54.9K	0.2%	68
2023 Q4	$812K	Sell	28,217 -239	-0.8%	-$7.22K	0.28%	51
2023 Q3	$944K	Buy	28,456 +239	+0.8%	+$8.45K	0.34%	37
2023 Q2	$1.03M	Sell	28,217 -824	-3%	-$32.1K	0.35%	28
2023 Q1	$1.18M	Buy	29,041 +800	+3%	+$34.6K	0.45%	24
2022 Q4	$1.45M	Buy	+28,241	New	+$1.35M	0.64%	17

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Park Edge Advisors's PFE Position: Q2 2026 in Review

Park Edge Advisors reduced its Pfizer (PFE) stake by 8.8% in Q2 2026, selling an estimated $51.8K and leaving 20,416 shares worth $492K. The position accounts for 0.1% of the portfolio, ranked #104.

Park Edge Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.45M in Q4 2022. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Park Edge Advisors held 20,416 shares of Pfizer worth $492K as of Q2 2026.
Park Edge Advisors sold 1,982 Pfizer shares in Q2 2026, an estimated $51.8K.
Pfizer made up 0.1% of Park Edge Advisors's portfolio in Q2 2026, its #104 holding.
Park Edge Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Park Edge Advisors's Pfizer position peaked at $1.45M in Q4 2022.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.